In conclusion, our study highlights the critical regulatory role of SmD2 in alternative splicing events and their impact on DNA damage pathways, underscoring their potential as a promising therapeutic avenue for HCC treatment. Here, SNRPD2 is linked to hepatocellular carcinoma.